Abstract
A case of late-onset (age 51) visual loss and night-blindness is presented to illustrate the challenges of diagnosis. This patient had anti-enolase antibodies, and demonstrates the importance of auto-immune retinopathy as a potential cause of late-onset retinal “dystrophy.”
This is a preview of subscription content, log in via an institution to check access.
References
Marmor MF, Holder GE, Seeliger MW, Yamamoto S. Standard for clinical electroretinography (2004 update). Doc Ophthalmol (2004) 108:107–114
Marmor MF, Hood DC, Keating D, Kondo M, Seeliger MW, Miyake Y (2003) Guidelines for basic multifocal electroretinography (mfERG). Doc Ophthalmol 106:105–115
Kaplan J, Bonneau D, Frézal J, Munnich A, Duffer J-L (1990) Clinical and genetic heterogeneity in retinitis pigmentosa. Hum Genet 85:635–642
Michaelides M, Hardcastle AJ, Hunt DM, Moore AT. (2006) Progressive cone and cone-rod dystrophies: phenotypes and underlying molecular genetic basis. Surv Ophthalmol 51:232–258
Adamus G, Ren G, Weleber RG (2004) Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol 4:5
Whitcup SM, Vistica BP, Milam AH, Nussenblatt RB, Gery I (1998) Recoverin-associated retinopathy: a clinically and immunologically distinctive disease. Am J Ophthalmol 126:230–237
Weleber RG, Watzke RC, Shults WT, Trzupek KM, Heckenlively JR, Egan RA, Adamus G (2005) Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies. Am J Ophthalmol 139:780–794
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Marmor, M.F. The dilemma of the late-onset “Dystrophy”. Doc Ophthalmol 114, 107–109 (2007). https://doi.org/10.1007/s10633-007-9046-0
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10633-007-9046-0